Gregory Wood, MD
Cardiovascular Disease · Missoula, MTNPI 1487821344
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,100 of the $6,316 with a category attached, or 80.7%. Abbott accounts for 92.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $5,253 and has fallen 91.2% since, to $463 in 2025.
Across 22 payments — averaging $287.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$6K
- Abiomed$333
- Medtronic$41
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$35
- Edwards Lifesciences$32
- Scpharmaceuticals Inc.$17
- plus $15 from 1 others
Across 21 payments — averaging $2924.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$61K
What the payments were for
- Consulting fees$5,10081%
- Food & beverage$1,21619%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 13 | $5,843 |
| Abiomed | 3 | $333 |
| Medtronic | 1 | $41 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $35 |
| Edwards Lifesciences | 1 | $32 |
| Scpharmaceuticals Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,316 in reported general payments places this provider in the 80th percentile of 49 cardiovascular disease providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 223 | $211,224 |
| EliquisApixaban | 142 | $168,690 |
| JardianceEmpagliflozin | 98 | $107,409 |
| BrilintaTicagrelor | 43 | $28,925 |
| XareltoRivaroxaban | 22 | $28,335 |
| FarxigaDapagliflozin Propanediol | 15 | $19,946 |
| Metoprolol Succinate | 361 | $7,522 |
| Torsemide | 130 | $4,100 |
| Flecainide Acetate | 37 | $2,714 |
| Carvedilol | 153 | $2,355 |
| Potassium Chloride | 67 | $2,143 |
| Spironolactone | 209 | $2,140 |
| Atorvastatin Calcium | 149 | $2,007 |
| Losartan Potassium | 135 | $1,507 |
| Eplerenone | 12 | $1,241 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Missoula
- Jocelyn SpoonMissoula$17K
- Patricia KellyMissoula$12K
- Newton CoutinhoMissoula$10K
- Michael ReedMissoula$8K
- Morgan KelloggMissoula$4K
- Ashley MaysMissoula$4K
- Matthew WeissMissoula$3K
- Puneet BansalMissoula$2K
- Alexander JehleMissoula$2K
- Jon McGregorMissoula$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.